RNA CapEx to Revenue
Atrium Therapeutics Inc · CapEx to Revenue
RNA CapEx to Revenue
Current (TTM)12.82%retrieved
RNA CapEx/Revenue (7.76% → 12.82%)
Latest values, visible window
High-resolution chart · PNG
RNA capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 7.7613% |